Excellence Is Never an Accident

Regenerative medicine is advancing rapidly, but it is also an industry where enormous differences exist between providers.

Not all stem cell treatments are created equally. Not all laboratories operate to the same standards.

Not all clinics manufacture, validate, test, administer, and follow patients with the same level of scientific rigor.

At Auragens, we have never believed that stem cells should be treated as a commodity. Every biologic administered to a patient represents months of scientific work, validation, quality assurance, and oversight before it ever reaches a treatment room.

That philosophy has become the foundation of everything we do.

A Platform—Not Just a Clinic

Over the past year, Auragens has continued building what Life Sciences Review described as an entire regenerative medicine platform, extending far beyond the traditional concept of a treatment center. From ethical tissue sourcing and in-house cell expansion to physician-led treatment, patient tracking, published research, and peer-reviewed science, every critical step remains under one integrated system of quality control.

This approach allows us to focus on what ultimately matters:

• Better biologics

• Better safety

• Better consistency

• Better patient outcomes

Because when every step is controlled, every step can be measured, validated, and continuously improved.

Raising the Standard

One of the defining milestones this year was achieving AABB accreditation, one of the world’s most respected quality standards for cellular therapies.

This accomplishment was the result of years of preparation and reflects our commitment to creating biologics that are safe, traceable, validated, and manufactured to the highest standards available. It represents something much larger than a certificate—it represents accountability.

Combined with our expanding scientific publications, long-term patient outcome tracking, physician education initiatives, and the launch of our dedicated OrthoBiologics Division, Auragens continues to invest in advancing the entire field—not simply our own organization.

Trust Must Be Earned

Stem cell therapy has tremendous potential. But potential alone is not enough.

Patients deserve transparency. They deserve evidence. They deserve physicians who welcome scrutiny rather than avoid it.

Everything we build—from our laboratory systems to our quality management programs to our patient follow-up protocols—is designed around one principle:

Trust is earned through science, not marketing.

That philosophy has guided Auragens since the beginning and continues to shape every decision we make.

Thank You

To our patients who have trusted us with their health.

To our physicians, scientists, nurses, laboratory professionals, and support staff who pursue excellence every day.

To our research collaborators and academic partners who challenge us to continue improving.

Thank you.

This recognition belongs to every member of the Auragens family.

Being named Stem Cell Treatment Center of the Year once was an incredible honor.

Being selected for a second consecutive year tells us something even more meaningful:

We’re moving in the right direction.

And we’re only getting started.